Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine for recovery after traumatic brain injury
IRCT20190618043934N18Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in traumatic brain injury (TBI) comparing Amantadine with Placebo (2 arms). Primary endpoint: Glasgow Coma Scale. Started Aug 2023; status: completed.
02
Drugs
amantadine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20190618043934N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190618043934N18.